LiVeritas Biosciences logo
HealthTech + BioTechHoldco Asset

LiVeritas Biosciences

πŸ‡ΊπŸ‡ΈUSA
Cohort 2020
liveritas.bio
CURRENT VALUATION
$20M
Mark-to-market holdco book value
ENTRY VALUATION
$1.4M
Pre-seed acceleration round
VINTAGE / COHORT
2020HOLDCO ASSET
Initial entry cohort
ECOSYSTEM TRACK
HealthTech
Global founder cohort

Company Overview

Uses liquid chromatography-mass spectrometry and machine learning to produce validated, submission-ready molecular testing data for biopharma.

Investment Thesis & Acceleration

Expert DOJO backed LiVeritas Biosciences during early acceleration to scale market distribution, assemble high-conviction syndicates, and expand operations into key international markets. The company exemplifies our core thesis of backing relentless operators solving urgent systemic workflows.

High-Margin ArchitectureAutonomous OperationsGlobal Addressable Market